NDUFB11
protein-codingNADH:ubiquinone oxidoreductase subunit B11, the group of NADH:ubiquinone oxidoreductase supernumerary subunits
Gene summary
The protein encoded by this gene is a subunit of the multisubunit NADH:ubiquinone oxidoreductase (complex I). Mammalian complex I is located at the mitochondrial inner membrane. This protein has NADH dehydrogenase activity and oxidoreductase activity. It transfers electrons from NADH to ubiquinone. Mutations in the human gene are associated with linear skin defects with multiple congenital anomalies 3 and mitochondrial complex I deficiency. [provided by RefSeq, Dec 2016]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~3.4 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: XL
Disease ID:MONDO:0026721
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: XL
Disease ID:MONDO:0044970
Submitter: ClinGen
The relationship between *NDUFB11* and primary mitochondrial disease was evaluated using the ClinGen Clinical Validity Framework as of January 20, 2022. *NDUFB11* encodes an accessory subunit of complex I of the mitochondrial respiratory chain. *NDUFB11* was first reported in relation to X-linked mitochondrial disease in 2015 (PMID: 25772934). While various names have been given to the constellation of features seen in those with *NDUFB11*-related disease, pathogenic variants in this gene cause a primary mitochondrial disease. Therefore, the *NDUFB11* phenotype has been lumped into one disease entity according to the ClinGen Lumping and Splitting Framework. Evidence supporting this gene-disease relationship includes case-level data and experimental data. This curation included eight unique variants, comprising four nonsense and frameshift variants, three missense variants, and one in-frame deletion, in 13 probands across seven publications (PMIDs: 25772934, 25921236, 26741492, 27488349, 28050600, 27102574, 30423443). More evidence is available in the literature, but the maximum score for genetic evidence (12 points) has been reached. Of note, *NDUFB11* pathogenic variants were initially reported in individuals with linear skin defects, failure to thrive, developmental delay, and histiocytoid cardiomyopathy. Subsequent publications have shown expansion of the phenotypic spectrum, ranging from isolated cardiomyopathy to multisystemic disorders including cardiomyopathy, optic atrophy, myopathy, short stature, and hearing impairment. The recurrent in-frame deletion, c.276_278del (p.Phe93del) has been reported in at least five probands (PMIDs: 27488349, 27102574) with a unique presentation of sideroblastic anemia with or without some of the multisystemic features described above. Loss-of-function is implicated as the mechanism of disease. This gene-disease association is also supported by the known biochemical function, rescue in a cell culture model, and animal models (PMIDs: 27509854, 25921236, 26741492, 27488349, 27102574). More evidence is available in the literature, but the maximum score for experimental evidence (6 points) has been reached. In summary, *NDUFB11* is definitively associated with X-linked mitochondrial disease. This has been repeatedly demonstrated and has been upheld over time. No convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Gene Curation Expert Panel on January 20, 2022 (SOP Version 8).
Inheritance Pattern: XL
Disease ID:MONDO:0010494
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: XL
Disease ID:MONDO:0026721
Submitter: PanelApp Australia
Inheritance Pattern: XL
Disease ID:MONDO:0010672
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Biochemical; Cardiovascular; Dermatologic; Neurologic
Intervention: Cardiovascular
Rationale: Among other findings, individuals have been described with early-onset cardiomyopathy, and awareness may allow prompt awareness and management
Comments: Cardiac transplantation has been described
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to NDUFB11 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001135998.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 15 | 16 | |||
| missense | 2 | 40 | 6 | 1 | 49 | |
| nonsense | 1 | 1 | 2 | |||
| start loss | 1 | 1 | ||||
| frameshift | 1 | 3 | 1 | 5 | ||
| splice donor/acceptor (+/-2bp) | 1 | 1 | 1 | 3 | ||
| Total | 2 | 7 | 44 | 22 | 1 | 76 |
Highest pathogenic variant AF is 0.000015485304
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001129470.1 | 3 | MANE Select | |
| Ensembl | ENSP00000367042.3 | 3 | MANE Select | |
| RefSeq | NP_061929.2 | 3 | Standard | |
| Ensembl | ENSP00000276062.9 | 3 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| ndufb11 | Danio rerio | Structure: trunk vasculature Quality: morphology abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Retrograde endocannabinoid signaling - Homo sapiens (human)
- Non-alcoholic fatty liver disease (NAFLD) - Homo sapiens (human)
- Alzheimer,s disease - Homo sapiens (human)
- Huntington,s disease - Homo sapiens (human)
- Thermogenesis - Homo sapiens (human)
Biological Process
- mitochondrial respiratory chain complex I assembly
- oxidation-reduction process
Molecular Function
- protein binding
Cellular Component
- mitochondrion
- mitochondrial inner membrane
- mitochondrial respiratory chain complex I
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000276062
- Coding exons
- 3
- Length
- 3289
- Individuals with no LoFs
- 0
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 0
- Defined
- 0
- p
- 0.00
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.513 | 54 | 65.7 | 0.822 | 0.00000506 | 1046 |
| Missense (PolyPhen) | 14 | 23.13 | 0.60527 | 388 | ||
| Synonymous | -0.292 | 30 | 28.0 | 1.07 | 0.00000227 | 333 |
| Loss of Function | 2.15 | 0 | 5.39 | 0.00 | 4.86e-7 | 71 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0 | 0.0 | absent |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone. {ECO:0000269|PubMed:27626371}.;
- Disease
- DISEASE: Mitochondrial complex I deficiency (MT-C1D) [MIM:252010]: A disorder of the mitochondrial respiratory chain that causes a wide range of clinical manifestations from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. {ECO:0000269|PubMed:26741492}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.335
Intolerance Scores
- RVIS EVS
- -0.05
- RVIS percentile EVS
- 49.39
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- H
- Indispensability pred.
- E
- Indispensability score
- 0.613
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Low | Medium |
| Primary Immunodeficiency | Medium | Low | Medium |
| Cancer | Medium | Medium | Medium |